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Age-related macular degeneration (AMD) is a disease of the macular area and is the most common cause of irreversible vision 
loss in people over 50 years of age. Many AMD risk factors, including aging, smoking, exposure to UV and blue light, chronic 
inflammation, and improper diet, can be associated with oxidative stress. In this regard, certain food ingredients and 
supplements that have antioxidant properties may contribute to the prevention of AMD and it's progression. Polyphenols can 
be considered as preventive and therapeutic compounds in the prevention of diseases associated with aging due to the 
antioxidant properties. For example, quercetin, present in onions, improves anti-VEGF therapy, which is the only effective 
drug for the wet form of AMD, while resveratrol, found in grape skin, red wine, blueberries and mulberries, neutralizes the 
negative effects of anti-VEGF therapy. Blueberry anthocyanins have a protective effect on induced damage of retina caused by 
blue light. Carotenoids that are part of the macular pigment; lutein and zeaxanthin, found in leafy green vegetables and eggs, 
have the ability to filter light ("natural sunglasses"), but also have direct antioxidant properties. Zinc and copper homeostasis in 
the retina-choroid complex also play a role in retinal health and AMD prevention. Adequate intake of omega-3 fatty acids, 
which are found in blue fish, nuts and seeds, reduces the risk of progression to the late stage of AMD. Oxidative stress can be 
exacerbated by improper diet, and thus increase the possibility of the occurrence and progression of AMD, which is why 
during the eye examination of persons at risk, it is necessary to advise on proper nutrition and appropriate supplementation. 
 




Age-related macular degeneration (AMD) is a 
medical condition of macula and is the most common 
cause of vision loss in persons over 50 years of age. 
There are two types of age-related macular 
degeneration: dry and wet form. 
Dry macular degeneration or ―early‖ stage of AMD is 
characterized with presence of yellow deposits 
(called drusen) in macula, hypo/hyperpigmentation of 
retinal pigment epithelium, which is often found in 
macula and posterior pole. Wet form of macular 
degeneration or ―late‖ stage of AMD is more serious 
condition and includes occurrence of choroidal 
neovascularization (CNV), retinal and subretinal 
bleeding, subretinal exudates, periretinal and retinal 
fibro-glial changes, geographic atrophy in RPE as 
well as pigment epithelial detachment (PED). Unless 
treated, wet form of macular degeneration can lead to 
dramatic decrease of visual acuity within a year 
(Andrijević Derk, 2015). 
Besides classic categorization on dry and wet 
macular degeneration, there are more detailed 
classifications. The classification of dry form of 
AMD relates to number and size of drusen and the 
changes in RPE. We discern, early stage (Fig. 1a) 
with soft drusen, 64-124 μm in size and light pigment 
changes on the posterior pole, and intermediate stage 
(Fig. 1b) with middle-sized drusen resulting in 
confluence and big drusen (> 125 μm) accumulated 
below retina. Late stage of ADM has two subtypes: 
wet, exudative or neovascular macular degeneration 
(Fig. 1c) and geographic atrophy or dry degeneration 
(Fig. 1d) (Ţorić et al., 2008). 
According to the literature, a dry form of AMD 
present in 10 - 20 % of patients progresses to wet 
form, where 40% of patients develop wet form of 
AMD on both eyes (Andrijević Derk, 2015). 
The data from EUREYE study (2006) shows that 
3.3% of the population over 65 years have some form 
of AMD on at least one eye (Andrijević Derk, 2015). 
It is believed that in Europe by 2040, the number of 
people with early AMD will be between 14.9 and 
21.5 million and those with late AMD between 3.9 
and 4.8 million (Colijn et al., 2017). 
AMD is the leading cause of blindness in developed 
world and among white population of USA and 
constitutes 9% of blindness on global level. It is 
estimated that in 2020, number of people suffering 
from AMD will be 196 million globally and in 2040 
that number will increase to 288 million (Chew, 
2020). The World Health Organization states that 
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currently there are 14 million people suffering from 
blindness or heavily damaged vision due to AMD 
which puts it as a major problem related to vision 
loss on a global level (Pawlowska et al., 2019). 
 
 
          a) Early stage of AMD                   b) Intermediate stage of AMD 
 
 
c) Late stage with neovascularization            d) Late stage with geographic atrophy 
 
Fig. 1. AMD stages (Čeklić et al., 2015) 
 
 
AMD risk factors and pathogenesis 
 
The main factor of AMD occurrence is age-related 
(50 years and above), then positive family history, 
smoking, previous operation of cataract, 
atherosclerosis, obesity followed by increased Body 
Mass Index (BMI), artery hypertension and 
cardiovascular diseases, insufficient intake of vitamin 
A, C and E, omega-3 fatty acids, zinc and lutein in 
diet, genetic predispositions (polymorphism related 
to complement H, ARMS2/HTRA1). Possible risk 
factors are: alcoholism, sun and UV exposure, intake 
of vitamin B, hormonal status and quantity of vitamin 
D, C reactive proteins and markers of inflammation 
(Čeklić et al., 2015). 
Smoking as a risk factor is connected with specific 
genetic factors. High levels of cadmium in urine, 
occurring in smokers suffering from maculopathy, 
indicates specificity in its elimination in this group. 
Smokers who do not suffer from maculopathy have 
significantly lower levels of this toxic metal (Erie et 
al., 2007). 
The mutation of the complement factor H (CFH) is 
probably the most noticeable genetic change in patients 
suffering from AMD (Warwick et al., 2018). Variability 
of several loci not included in the complement system 
plays an important role in AMD pathogenesis. Those are 
ARMS2 gene (Age-Related Maculopathy Sensitivity 2 
gene) on chromosome 10 and genes included in 
angiogenesis (TGFBR1, VEGFA), the high-density 
cholesterol pathway -HDL (APOE, CETP i LIPC) and 
immunity regulation (PILRB) (Toomey et al., 2018). 
Epigenetic regulation of gene expression should also be 
included in the studies related to AMD pathogenesis, but 
epigenetic mechanisms in AMD early development are 
less known than genetic mechanisms. White people and 
females are most commonly connected to this disease. 
However, besides age, family medical history, 
genetic predisposition and smoking, other risk factors 
are still controversial and require further examination 
Nejra Hodžić et al. / AGE-RELATED MACULAR DEGENERATION... (2021) 10 (1) 14-23 
16 
in order to confirm their participation in AMD 
pathogenesis (Pawlowska et al., 2019). 
AMD is multifactorial disease which is mainly 
caused by the changes in RPE structure and 
metabolism as a consequence to changes in Bruch’s 
membrane (BM) caused by aging of the organism. 
All of these changes start with the fourth decade of 
life and are expressed more with age, and the result is 
change in RPE metabolic activity. BM in macula is 
more affected with metabolic changes than peripheral 
BM due to higher density of photoreceptors in 
macula and RPE metabolic activity. Metabolic 
activity of RPE involves a complex process of 
removing products of photoreceptors activity (rods 
and cones), which are at the same time regenerating, 
removing damaged membrane parts and organelle 
cytoplasm which due to change in transport through 
Bruch’s membrane, are accumulated in the form of 
basal laminar deposit (BlamD) and basal linear 
deposit (BlinD), drusiform changes (D) in the area of 
cytoplasm of RPE and basal membrane of RPE and 
Bruch’s membrane. Changes within collagenous and 
elastic layer of Bruch’s membrane lead to 
mineralization of elastic layer as well as thickening 
of membrane from 2 μm during the first ten years of 
life up to 4.7 μm in the nineth decade of life. Moore's 
and Clover’s study shows tenfold decrease in 
transport through Bruch’s membrane between the 
first and ninth decade of life, with all of the changes 
being more expressed in macular area in comparison 
to periphery (Andrijević Derk, 2015). 
It is generally accepted that oxidative stress plays an 
importantrole in pathogenesis of AMD, but the 
source of oxidative stress in AMD is not generally 
known. AMD, especially wet form, is linked to 
several changes in retinal vascularization, which can 
be attributed to aging or intensive flow of blood in 
this tissue. These changes along with genetic 
predisposition of an individual, environmental factors 
and lifestyle represent major pathogens of AMD 
(Pawlowskaet al., 2019). 
Retina is exposed to sun radiation during the lifetime. 
It is considered that the blue part of solar spectrum 
has more significant impact here because cornea and 
lens absorb the most part of UV radiation (Ţorić et 
al., 2008). Retina has the highest speed of 
metabolism among tissues in the human body, has a 
large need for oxygen and is highly susceptible to 
oxidative stress (Datta et al., 2017). Oxidative stress 
is the condition leading to disbalance between 
antioxidants and prooxidants, in favor of prooxidants. 
In the balanced conditions, free radicals are dissolved 
by antioxidants of the cells with the help of enzymes 
(superoxide dismutase, catalase, glutathione 
peroxidase) or nonenzymatic with the help of 
glutathione. Long term oxidative stress leads to the 
damage of biological macromolecules (DNA, lipids, 
proteins and carbohydrates) causing disbalance of 
homeostasis in the cell and later in the tissue 
(Brzović Šarić, 2014). Oxidative damage of lipids - 
lipid peroxidation has the major role in AMD 
pathogenesis. Photoreceptor membranes contain a lot 
of polyunsaturated fatty acids (PUFA), a source of 
reactive oxygen species (ROS). Chronical exposure 
to light results in the ROS production. The cells of 
retinal pigment epithelium are of crucial significance 
for phototransduction because they phagocyte old 
tips of photoreceptors outer segments (Sun et al., 
2006). Lipofuscin comes as a byproduct of 
phagocytosis (Delori et al., 2001). Lipofuscin 
contains complex compound of bis retinoid 
fluorophore which are causing autofluorescence of 
the fundus of the eye (Sparrow et al., 2012). The 
main fluorophore is A2E (N-retinylidene-N-
retinylethanolamine), pyridiniumbisretinoid. When 
A2E is exposed to blue light, it succumbs to 
photooxidation which results in the ROS production 
and lipid peroxidation. Oxidative processes in retina, 
especially those happening during aging of macula 
can contribute to AMD pathogenesis. Aging, main 
risk factor of AMD occurrence, is related to ROS 
over-production in different ways, including lower 
levels of antioxidants, antioxidative enzymes and 
accumulation of damages on mitochondrial DNA 
(mtDNA). Macula concentrates light and shows high 
metabolic activity and oxygen consumption related to 
intensive flow of blood. Retina has limited 
regeneration mechanism and does not possess stem 
cells which could produce new cells to replace dead 
ones. 
Environmental factors and lifestyle, including 
exposure to blue light, smoking, and improper diet 
increase ROS production. However, some nutritive 
supplements can inhibit oxidative stress related to 
ROS over-production and alleviate retinal damage. 
Retinal antioxidant defense can directly inhibit 
oxidative stress and its byproducts including lipid 
peroxidation, but is decreasing with age; limited 
regeneration mechanisms and regeneration of retina 
also decreases with age, as shown in fig. 2 
(Pawlowska et al., 2017). 
Many factors that can increase the risk of AMD, 
including smoking, exposure to UV and blue light, 
chronic infections and improper diet, could be related 
to oxidative stress, but it is not known if oxidative 
stress is a part of occurrence or consequence of the 
disease or both. In any case, reduction of stress can 
be extremely important in the prevention and therapy 
of AMD. 
 





Fig. 2. Risk factors, oxidative stress and the impact of retinal damage in pathogenesis of AMD with representation  
of defense mechanism; influence of proper diet, retinal antioxidative system and retinal regeneration mechanisms,  
which decrease with age (Pawlowska et al., 2019) 
 
 
Antioxidants in retina 
 
Retina has more elements of antioxidant defense; 
vitamin C and E, carotenoid, lutein and zeaxathin are 
often considered the most important (Carneiro et al., 
2017). 
Vitamin C and E are well-known antioxidants. 
Both vitamins contribute to the reduction of retinal 
epoxy adduct as well as the prevention of damages 
caused by blue light (Sparrow et al., 2003). 
Vitam E or α-tocopherol can prevent chain reaction 
of ROS during the attack on the cell membranes. In 
order to stabilize ROS, α-tocopherol is turned to α-
tocopherol radical which has stable and not reactive 
form. α-tocopherol radical can be regenerated in its 
original form with reactions involving vitamin C, 
glutathione and lipoic acid. Antioxidant capabilities 
of α-tocopherol depend on the concentration of those 
compounds which maintain α-tocopherol in reduced 
state in cases of oxidative stress. It is possible that 
ROS over-production can cause significant decrease 
of active vitamin E concentration in tissue. α-
tocopherol is discovered in lens, aqueous humour and 
retina (Penn et al., 1992). 
Carotenoid lutein, zeaxathin and meso-zeaxanthin 
form macular pigment (MP). Their role is to act as 
antioxidants and protectors of photoreceptors (rods 
and cones) from blue light (Lawrenson et al., 2019). 
The biggest concentration of carotenoid is in the 
plexiform layer of macula; zeaxathin dominates in 
the inner part of the macula - fovea, while lutein is 
spread in the peripheral part of retina (fig. 3). This is 
the reason why zeaxanthin is more efficient as an 
antioxidant in the area where risk from oxidation is 
more likely to happen (Handelman et al., 1988). The 
concentration of zeaxanthin in fovea is 2.5 times 
greater than lutein (Widomska et al., 2020).Both 
carotenoids are present in photoreceptors outer 
segment: rods and cones which are rich with 
docosahexaenoic acid (DHA) and are potentially 
sensitive to lipid oxidation (Carneiro et al., 2015). 
DHA composes 60% of photoreceptors lipidic 
membrane and represents a main structural lipid of 
retina (Souided et al., 2013). DHA can be synthetized 
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from eicosapentaenoic acid (EPA) and its main 
source comes from diet. Health benefits come from 
the ability of DHA and EPA to reduce the production 
of inflammatory eicosanoids, cytokines and ROS 
(Calder, 2009) and modulation of many gene 
expression which are involved in inflammation 
(Bouwens et al., 2009). Anti-inflammatory effects 
can inhibit the production of new choroidal vessels 
which can be visible in exudative AMD (Querques et 
al., 2014). Omega-3 fatty acids (EPA and DHA) are 
delivered to photoreceptor membranes through RPE. 
Every disbalance in the lipids of photoreceptors can 
contribute to the production of drusen in the layers of 
RPE (Carneiro et al., 2017) which are the beginning 




Fig. 3. Topography of macular pigment, schematic view of the distribution of yellow macular pigment on retina:  
horizontal (up) and vertical section (down) (taken from Arunkumar et al., 2018) 
 
 
Supplements and AMD 
 
There is evidence from randomized clinical studies 
that prophylactic intake of antioxidants in the form of 
vitamins and minerals does not prevent the 
development of AMD. Five big randomized clinical 
studies compared the intake of supplements 
containing vitamin E, beta-carotene, vitamin C or 
antioxidant combination of vitamins with placebo. 
The studies randomized more than 75.000 people and 
tracked their clinical results between 4 and 10 years. 
It is discovered that people who take the supplements 
have the similar risk of AMD development as those 
who do not take the supplements (Ewans et al., 
2017). 
Many randomized clinical studies also tackled the 
question of whether or not high dosages of 
antioxidants in the form of vitamins and minerals can 
slow down the AMD progression (Ewans et al., 
2017). The majority of studies attracted small number 
of participants and were relatively short in duration, 
the span from 9 months up to 6 years. However, one 
big, multicentricrandomized clinical study conducted 
in the USA, age-related eye disease study -AREDS, 
randomized 3640 individuals with AMD and had 
them take supplements to the formulations which 
contain combination of vitamin C, E, beta-carotenes, 
zinc or copper or placebo each day. The main 
conclusion was that daily, long-term supplementation 
of vitamin C (500 mg), vitamin E (400 international 
units (IU)), beta-carotene (15 mg), zinc (80 mg, in 
the form of zinc oxide) and copper (2 mg, in the form 
of copper oxide) decreases the relative risk of AMD 
progression to the late stage (Lawrenson et al., 2019). 
The result achieved with patients who joined the 
study at later stages of diseases, to be more precise 
intermediate stage, up to more advanced stages, is 
25% progression decrease in 5 years, while the effect 
on the patients in the early stages is still unknown. 
Besides AREDS, Report No8 concludes that patients 
with noncentral geographic atrophy also have the 
benefits of taking antioxidants and zinc. 
Since it is established that smokers have increased 
incidence of lung carcinoma, the next AREDS2 study 
showed that removing beta-carotenes or lowering the 
dosage of zinc in the formula does not have the 
impact on the progression to the late stage of AMD 
(ČajkušićMance et al., 2019). Increased incidence of 
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lung carcinoma is recorded with patients who took 
AREDS formula as opposed to ones who took 
AREDS2 formula, especially with former smokers 
due to high dosages of beta-carotenes. Primary 
AREDS2 analysis showed that adding lutein and 
zeaxanthin and/or omega-3 fatty acids in the AREDS 
formula is not linked to significant reduction of risk 
of late-stage AMD progression in comparison to the 
original supplement (AREDS formula). Lutein and 
zeaxanthin are carotenoids which are main 
components of macular pigment. They have 
protective role in retina due to their antioxidant 
properties and abilities to act as filters of blue light. 
The analysis of AREDS2 suggested that lutein and 
zeaxanthin can be useful in the reduction of AMD 
progression if they are taken without beta-carotenes 
(Lawrenson et al., 2019). 
Lutein, zeaxanthin and meso-zeaxanthin form 
macular pigment (MP). Lutein is precursor of meso-
zeaxanthin and recently RPE65 is identified as an 
isomerase enzyme responsible for conversion of 
lutein to meso-zeaxanthin in RPE of vertebrate 
(Shyam et al., 2017). MP’s primary function is 
lowering the dispersion of blue light in inner retina, 
and dark yellow color and anatomic position of MP 
are considered to be ideal for protection of foveal 
region from photo-oxidative damages (Arunkumar et 
al., 2018). Lutein filters blue light more efficiently 
than zeaxanthin and meso-zeaxanthin due to its 
orientation in lipid bilayer (Sujak et al., 1999). Many 
studies speak in favor of protective antioxidant 
abilities of carotenoid which are part of MP. Barker 
et al. (2005) in their study conclude that primates 
which are, from their birth, fed with food without 
carotenoid, are more prone to damages resulting from 
blue light. Photoreceptor cells are more prone to 
oxidation in comparison to other cells of retina 
because they contain a lot of polyunsaturated fatty 
acids in the membrane structure and lean on 
carotenoid in protection of oxidation stability. 
Chucair et al. (2007) showed that retinal neurons in 
rats which were treated with macular carotenoids 
have greater protection from oxidative stress then 
untreated group. With identification of lutein and 
zeaxanthin oxidative metabolites in retina, Khachik 
et al. (1997) further support the function of macular 
pigment in oxidative protection of retina. 
Previous studies showed that individuals who are 
using computers or smartphones longer than 6 hours 
per day had the benefits from supplementation of 
carotenoids, not only in increased visual efficiency 
but also in better quality of sleep, reduction of 
headaches, eye fatigue and photophobia. Thus, 
supplementation of macular pigment in certain form 
can be beneficial even to those who are not suffering 
from AMD (Arunkumar et al., 2018). 
The benefits of polyphenols in AMD include other 
antioxidant mechanisms besides removal of ROS. 
Dietary polyphenols (phenols) are numerous and 
heterogeneous groups of chemicals found in plants 
and beverages. They can be categorized in several 
groups and according to chemical structure, can be 
divided into following groups: phenolic acids 
(benzoic and cinnamic acid), flavonoids 
(isoflavonoids, neoflavanoids, chalcones, flavones, 
flavonoids, proanthocyanins, anthocyanidins). Other 
bioactive polyphenols, also important for the health 
of humans, are curcumin, resveratrol and ellagic acid 
(Pawlowska et al., 2019). Polyphenols show effects 
against aging, and therefore can be considered as 
preventative compounds in diseases related to aging 
which are usually induced by chronic oxidative stress 
and accumulation of their products (Khurana et al., 
2013). 
Bioavailability of polyphenolic compounds in human 
eye can be high. In perfusion system of rats in situ, 
bioavailability of quercetin was 20% of applied 
dosage (Crespy et al., 2003). High bioavailability of 
anthocyanins is recorded in ocular tissues after 
different ways of applications (Kalt et al., 2008). 
These and other reports suggest that flavonoids, 
including quercetin and anthocyanins can surpass the 
blood-retina barrier after oral application, as well as 
after acute intravenous and intraperitoneal 
application (Pawlowska et al., 2019). 
So far, no therapy has been approved or confirmed 
for the treatment of geographic atrophy of severest 
form of ―dry‖ AMD which represents subtype of late-
stage AMD, while wet form of AMD is treated 
moderately successful with inhibitors of vascular 
endothelial growth factor (anti-VEGF). Multiple 
studies are currently searching for effective way of 
treating dry form of AMD. 
In connection to that, it is known that quercetin 
inhibits choroidal neovascularization (CNV) induced 
by laser radiation in the eyes of rabbits in vivo and in 
vitro (Zhuang et al., 2011). This flavonoid improved 
the blood flow of choroidea and reduced migration of 
umbilical vein endothelial cells during the wound 
healing. Therefore, it can be considered that 
quercetin improves anti-VEGF therapy which is the 
only effective treatment of wet form of AMD 
(Sulaiman et al., 2014). Patients suffering from wet 
form of AMD receive a number of intravenous 
injections against VEGF but there are signals that 
anti-VEGF treatment can potentially increase the 
development of geographic atrophy (Gementzi et al., 
2017). The most used Bevacizumab (Avastin) has 
side effects because it neutralizes all VEGF extracted 
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from RPE cells, which leads to disbalance in RPE 
homeostasis (Ford et al., 2011). Namely, VEGF is 
necessary for maintenance of retinal structure. 
Subramani et al. (2017) proved that combined 
activity of Bevacizumaba and resveratrol only 
partially neutralized extracted VEGF in ARPE-19 
cells in comparison to cells which were treated 
individually with Bevacizumaba, when it came to 
neutralization of all VEGF. Resveratrol also showed 
synergistic protective effects together with 
zeaxanthin (Pawlowska et al., 2019). Park et al. 
(2017) state that antiapoptotic effect of curcumin 
extract (Curcuma longa L., Zingiberaceae) and its 
curcuminoids on cytotoxicity caused by exposure of 
ARPE-19 cells previously filled A2E to blue light. 
Similarly, polyphenolic components of Vaccinium 
uliginosum extracts containing flavonoids, 
anthocyanidins, phenylpropanoids and iridoids 
decrease ARPE-19 cell death caused by A2E 
photooxidation (Lee et al., 2016). Vaccinium 
uliginosum L., Ericaceae represent black or bog 
blueberry. Anthocyanidins in wild blueberries 
contribute to health of eyes, and cyanidin-3-glucoside 
in blueberries represent functional food for 
prevention of diseases related to retina (Wang et al., 
2017). Many studies showed the protective effect of 
polyphenols found in blueberries on the retinal 
damages induced by light with lipid peroxidation 
(Ma et al., 2018). 
Average level of zinc in the complex RPE - 
choroidea in patients suffering from AMD is reduced 
by 24% in comparison to others without AMD. 
Average level of copper in the complex RPE - 
choroidea in patients suffering from AMD is reduced 
by 23% in comparison to others without AMD, even 
though there was no difference in the levels of zinc or 
copper in the retina of people which have and don't 
have AMD. These results in combination with other 
information that oral supplementation of zinc and 
copper decreases the risk of AMD progression, 
suggests that homeostasis of these minerals play a 
role in AMD and retinal health (Erie et al., 2009). 
 
Diet and AMD 
 
Mediterranean diet, rich with whole grains, fresh 
season vegetables and fruits, beans, olive oil, nutty 
fruits, fish, herbs and red wine is tested in 
randomized controlled clinical research in order to 
show the beneficial effects in mitigation of 
cardiovascular diseases. It is discovered that 
Mediterranean diet is linked to a reduce risk of 
suffering from AMD. It is known that specific 
nutritious substances such as lutein and zeaxanthin 
found in leafy green vegetables, such as kale, are 
linked to a reduced risk of suffering from AMD. Fish 
is another important component of Mediterranean 
diet linked to a reduced risk of suffering from AMD 
and it is recommended to have fish two times per 
week (Chew, 2020). 
Western diet is linked to a greater prevalence of 
AMD. Vegetable oils and animal fats containing 
omega-6 fatty acids, and red and refined meat needs 
to be consumed minimally in order to reduce the risk 
of AMD progression. Diet with high glycemic index 
and alcohol consumption of more than two drinks per 
day showed connections with AMD (Chapman et al., 
2019). 
Examination of the fundus which corresponds to the 
intermediate stage of AMD will in 50% of cases, 
during the next five years, and in 71% of cases, in the 
next ten years, advance to the late stage of AMD 
(Čeklić et al., 2015). Owing to the protective effect of 
vitamin C, E, carotenoid; lutein and zeaxanthin, 
polyphenols, zinc and copper, which can be taken 
with diet and above all Mediterranean diet and/or 
dietary supplements can reduce the risk of AMD 
progressing to late stages. 
The recommendation regarding Mediterranean diet 
are intake of food rich with antioxidants and 
biologically active components, and reduced intake 
of saturated fatty acids and ingredients with higher 
glycemic index. 
Biologically active components of food are non-
nutritive and nutritive ingredients, and they have 
beneficial effect on health if consumed moderately. 
These include already mentioned polyphenolic 
compounds; resveratrol found in the grape skin, red 
wine, blueberry, raspberry and mulberry, quercetin 
found in onion and apples, curcumin found in ginger, 
safflower, curcumin, anthocyanins in blueberry 
(Jašić, 2010). Their positive effects are especially 
visible in neovascular AMD whether supporting the 
effects of anti-VEGF therapy such as quercetin or 
decreasing side effects caused by anti-VEGF therapy 
in case of resveratrol (Pawlowska et al., 2019). 
Besides polyphenolic compounds, under biologically 
active components we will include  carotenoid, beta-
carotene found in sweet potato, carrot, leafy green 
vegetables, apricot, peaches then xantofils; lutein 
found in goji berries, spinach, kale, eggs; zeaxanthin 
found in corn and eggs. Omega-3 fatty acids are also 
included in biologically active components, and their 
main sources are blue fish (pilchard, mackerel, 
salmon, cod, tuna), seeds (flex seeds, chia and 
sesame seeds) and nutty fruits (nuts, hazelnut, 
almond) (Jašić, 2010). 
Oxidative stress which has an important role in 
pathogenesis of AMD can be increased with 
improper diet (Pawlowska et al., 2019). 
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Adherence to Mediterranean diet is connected to 
reduced risk of drusen growth which can have a 
beneficial effect in all stages of AMD.Variable 
factors, such as healthy diet, could play and 
important role in delaying the progression of early 
stages of AMD (Merle et al., 2020). 
This would suggest that it is never too early or too 
late to accept healthy diet such as Mediterranean one. 
It is especially beneficial for geographic atrophy for 
which we do not have proven therapy and because 
AREDS2 supplements have beneficial effect on 
persons with neovascular AMD. 
It appears there is a dosage-answer relationship; 
therefore, the more we adhere, the greater reduction 
of progression to late stages of AMD (Chew, 2020). 
Diet rich with polyphenols has beneficial effects on 
many factors of risk related to AMD such as obesity, 
hypertension and hypercholesterolemia and it is 
proven that healthy diet reduces genetic risk of 
obesity (Pawlowska et al., 2019). 
Choosing Mediterranean diet and physical activity 
and avoiding smoking and sedentary lifestyle can 
reduce the prevalence of early AMD, number of 
individuals developing advanced AMD and 
consequently reduce the burden on healthcare system 
which is caused by the treatment of this disease 
(Carneiro et al., 2017). 
Study conducted in Japan proves the effects of diet. It 
involved 161 subjects with neovascular AMD and 
369 subjects pertaining to control group. Subjects 
filled out a questionnaire about how frequent they 
consume 58 ingredients in the last month. Analysis of 
their dietary habits proved many claims about the 
connection between frequency of consumption of 
omega-3 fatty acids, vitamin E, zinc, vitamin D, 
vitamin C and beta-carotenes and neovascular AMD. 
They proved reversed connection between 
consumption of omega-3 fatty acids and neovascular 
AMD. However, not a single study researched the 
effect of higher dosage intake of omega-3 fatty acids 
than those included in typical Japanese diet on 
neovascular AMD. Blue Mountains Eye Study 
(Australia) showed the protective effect of omega-3 
fatty acids in late AMD, among those with highest 
quintile intake. Participants in AREDS which 
reported highest intake of omega-3 fatty acids also 
had significantly lower probability for neovascular 
AMD. However, in AREDS2, adding DHA + EPA to 
original formulation has not additionally reduced the 
risk of AMD. As already discussed, the cause of that 
could be inadequate dosage or inadequate length of 
treatment or both (Aoki et al., 2016). 
In Japan, there was a descending trend between zinc 
intake and neovascular AMD which further 
supported the claim about protective effects of zinc 
on neovascular AMD. It should be noted that high 
dosage of zinc (80 mg zinc oxide), which can only be 
achieved with supplementation, in AREDS is enough 
to reduce the risk of neovascular AMD progression. 
The same study showed that the vitamin E and 
vitamin C intake is linked to reduced risk of 
neovascular AMD. However, it appears that there is a 
limit and further studies which would involve more 
subjects in order to determine whether or not vitamin 
C is enough to reduce the risk of neovascular AMD 
are needed. AREDS showed that high dosage of 
vitamin C and E and beta-carotenes is not enough. It 
is required to add zinc in order to reduce the risk of 
neovascular AMD and the dosage of 400 IU of 
vitamin E recommended by AREDS is 13 times 
higher than the recommended daily allowance -RDA. 
Such levels of vitamin E can only be reached with 
supplementation (Aoki et al., 2016). 
It is discovered in several studies that vitamin D 
reduces the risk of early AMD and has anti-
inflammatory properties (Pahlet et al., 2013). 
Numerous genes included in inflammatory response 
are connected with AMD. Current study showed that 
vitamin D is linked to neovascular AMD. Fish is a 
source of vitamin D as well as omega-3 fatty acids 
(Nakamura et al., 2002), therefore increased intake of 
fish can be confusing factor because it is not known 
whether the positive effect comes from vitamin D or 
omega-3 fatty acids. 
Lastly, by using the short questionnaire about the 
dietary history, they showed that the high intake of 
omega-3 fatty acids, vitamin E, zinc, vitamin D, 
vitamin C and beta-carotenes is linked with reduced 




AMD is an important cause of vision loss globally. 
Therefore, it is really important to recognize the risk 
factors which can be influence on such as smoking, 
obesity, atherosclerosis and improper diet. Proper 
diet, above all Mediterranean diet rich with 
antioxidants, minerals, vitamins and polyphenols has 
certain beneficial effect on prevention and 
progression of AMD, which is the reason 
consultations regarding proper diet and 
supplementation is needed during eye examination of 
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